All In Biotech

Drug Trial Radar · NCT00102479

Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents

A Phase II Study to Test PK Tolerability in Children and Adolescents

Last checked: Nov 20, 2026Latest source record: Jun 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

21

Actual

Start

Jul 1, 2004

Primary completion

Jul 1, 2005

Study completion Jul 1, 2005

Sponsor

Sponsor type
Industry
First posted
Jan 31, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 10 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this trial is to assess the safety, tolerability and pharmacokinetics of aripiprazole tablets following oral administration to children and adolescents.

Conditions

  • Schizophrenia
  • Mania

Interventions

  • AripiprazoleDrug

    Aripiprazole tablets ranging from 2 to 30 mg to be taken orally once a day.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Able to Tolerate Maximum Dose LevelTime frame: 14 Days
  2. Number of Participants With Adverse Events, Serious Adverse Events and Discontinuation Due to Adverse Event as a Measure of SafetyTime frame: 57 days
  3. Aripiprazole Maximum Steady State Plasma Concentration (Css,Max)Time frame: Pre-dose and 1 to 24 hours post-dose on Day 14
  4. Aripiprazole Time to Maximum (Peak) Plasma Concentration (Tmax)Time frame: Pre-dose and 1 to 25 hours post-dose on Day 14
  5. Aripiprazole Area Under the Concentration-Time Curve at Steady-State (AUCτ)Time frame: Pre-dose and 1 to 24 hours post-dose on Day 14

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.